Search Results
Jan 16, 2026, 18:22 ET Lightera Advances Fiber-integrated Temperature Feedback for Safer Laser-based Medical Procedures
solutions for specific clinical use cases.Learn more at BiOSJoin Lightera's presentation: "Temperature sensing for medical phototherapy in shape sensing endoscope fiber" 11:50 AM | Saturday, January 18, 2026 | BiOS, Moscone South, Room 307 (Level 3)About Lightera Lightera
More news about: Lightera, LLC
Jan 15, 2026, 17:31 ET Hemophagocytic Lymphohistiocytosis Market Poised for Phenomenal Expansion in the US at a CAGR of 24.5% During the Forecast Period (2025-2034) | DelveInsight
(r-hIL-18BP) (AB2 Bio). Despite all being in late-stage development, this underscores the scarcity of therapeutic innovation in this space.AB2 Bio's Tadekinig alfa is an innovative recombinant human IL-18 binding protein (IL-18BP) that neutralizes IL-18, a key pro-inflammatory cytokine. Under
More news about: DelveInsight Business Research, LLP
Jan 14, 2026, 14:04 ET Utah Valley University President to Step Down in May
leave ready and prepared to make a difference in the world. For more information, visit UVU's Newsroom website for fact sheets, maps, leadership bios, history, photos, b-roll, filming policies and a list of interview-ready faculty experts at
More news about: Utah Valley University
Jan 13, 2026, 17:31 ET Macrophage Activation Syndrome Market in the 6MM to Witness Upsurge in Growth at a CAGR of 24.7% During the Forecast Period (2025-2034) | DelveInsight
elimination of disease-driving immune cells. This innovative mechanism offers potential therapeutic value across a broad range of conditions.AB2 Bio's Tadekinig alfa is a novel recombinant form of human interleukin-18 binding protein (IL-18BP) that neutralizes IL-18, a key pro-inflammatory cytokine.
More news about: DelveInsight Business Research, LLP
Jan 13, 2026, 12:33 ET Adimab Records Another Year of Double-Digit Clinical Program Growth
injection), a PCSK9 program approved in China for the treatment of adult patients with primary hypercholesterolemia and mixed dyslipidemia.IASO Bio's FUCASO® (equecabtagene autoleucel), a BCMA CAR-T program approved in China for the treatment of patients with multiple myeloma.Invivyd's
More news about: Adimab, LLC
Jan 13, 2026, 10:00 ET Boats Group Introduces Verified: Showcasing the Brand, Credentials, and Expertise of Dealers and Brokers - Directly on Their Boat Listings
visual trust indicatorsProminent company branding within the listingDealer/Broker bios and professional photos to showcase the people behind the businessKey business details surfaced at the moment
More news about: Boats Group
Jan 12, 2026, 09:45 ET IndyGeneUS Bio Files Patent for Clinico-Genomic Insight Engine™, Advancing their AI×Bio Factory Hub from Baltimore to Africa
Genomics—capable of transforming population-scale genomic data into durable biomedical and therapeutic assets."The core engine of IndyGeneUS Bio's AI×Bio Factory is CGIE™, which integrates secure whole-genome sequencing workflows, high-performance computing, and audit-ready data governance into
More news about: IndyGeneUS Bio
Jan 08, 2026, 11:00 ET 技嘉於 CES 2026 發表全球首創 CQDIMM 技術 實現 256GB 滿載 DDR5-7200 極限效能
CES 2026 正式發表全球首創 CQDIMM（Clocked Unbuffered Dual In-Line Memory Module）技術，為高效能記憶體應用帶來重大突破。透過支援 CQDIMM 的主機板 Z890 AORUS TACHYON ICE CQDIMM Edition 與獨家 BIOS 調校技術，以兩條 128GB 記憶體，滿載 256GB 容量，首創 DDR5-7200 業界紀錄，突破過往高容量與高頻率無法兼得的限制。
More news about: GIGABYTE
Jan 08, 2026, 11:00 ET GIGABYTE Announces World's First DDR5-7200 at Full 256GB with CQDIMM at CES 2026
operation even under heavy workloads. Complementing the hardware advancements is GIGABYTE's sophisticated BIOS tuning technology. Through an optimized clock driver architecture, GIGABYTE's BIOS intelligently manages timing, signal synchronization, and voltage behavior to unleash extreme performance. The
More news about: GIGABYTE
Jan 08, 2026, 08:25 ET Immorta Bio Doubles Mouse Lifespan Using Combination Senolytic and Regenerative Therapy in Validated Aging Models
SenoVax™, we enable breakthrough personalized regenerative stem cells to restore function in ways not achievable with either approach alone."Immorta Bio's dual-platform strategy targets two fundamental hallmarks of aging: accumulation of senescent cells, addressed by SenoVax™, and loss of regenerative
More news about: Immorta Bio Inc.
Jan 08, 2026, 07:30 ET KAHR Bio Announces Strong Topline Phase 2 Results for DSP107 in Combination with Anti-PD-L1 Therapy in Colorectal Cancer
significant unmet medical need, and in our team's ability to execute as we move toward our next milestones."About DSP107 DSP107, KAHR Bio's lead drug candidate, is a first-in-class, bispecific CD47×4-1BB targeting, next-generation T-cell engager. DSP107 utilizes tumor-expressed CD47 as an
More news about: KAHR Medical
Jan 07, 2026, 08:13 ET PI at Photonics West: See the Latest Advancements in Nanopositioning Automation and Precision Motion Control
… in San Francisco, January 17 – 22, Booths 8517 (BIOS) / 3517 (PW) South Lobby, or visit our Tech Center in Fremont, CA.SAN FRANCISCO, Jan. 7, 2026 /PRNewswire/ -- Ready to scale high-tech manufacturing in 2026? Check
More news about: PI (Physik Instrumente) LP
Jan 06, 2026, 12:33 ET Leen Kawas Welcomes Life Sciences Executive Laurie Heilmann to Propel Bio Partners as Venture Partner to Strengthen Strategic Leadership
success. Her leadership will be instrumental as we accelerate technologies that improve human health."The appointment underscores Propel Bio's commitment to providing its portfolio companies with hands-on, operational support that extends beyond financial investment. In her new role, Heilmann
More news about: Propel Bio Partners
Jan 06, 2026, 12:30 ET ASUS Unveils Full-Spectrum AI and Always Incredible Innovations at CES 2026
ASUS ExpertGuardian, which protects devices with secured-core PC technologies, biometric authentication, and enterprise-grade BIOS and driver support services. With the rigorous MIL-STD-810H military-grade test and standard ASUS 3-year warranty, you can enjoy an extra peace of mind
More news about: ASUS Computer International
Jan 06, 2026, 08:30 ET ABS Bio Acquires Cureline, Broadening Access to Biospecimens & Streamlining Execution from End to End
access to biospecimens, flawless execution, and outstanding customer experience from initial request to delivery."Cureline will strengthen ABS Bio's position as a premier partner in specimen procurement, cell culture, and histology. The transaction expands the Company's capabilities and scale for
More news about: 3 Boomerang Capital
Jan 06, 2026, 07:03 ET Variant Bio Launches Inference, the World's First Agentic AI Genomic Drug Discovery Platform
and harmonized data from major genetic and multi-omic association studies, and numerous global biobanks, alongside proprietary datasets from Variant Bio's studies with underrepresented populations. The platform has processed hundreds of billions of genetic associations across tens of thousands of genome-wide
More news about: Variant Bio
Jan 06, 2026, 07:00 ET Variant Bio Announces Strategic Target Discovery Collaboration with Boehringer Ingelheim for Kidney Disease
Multi-year alliance leveraging Variant Bio's AI-powered Inference platform to discover novel drug targets for kidney diseaseFinancial terms include upfront, license, and milestone payments potentially exceeding $120 millionSEATTLE,
More news about: Variant Bio
Jan 06, 2026, 00:45 ET GIGABYTE revela "Refine & Define", moldando o futuro da computação com IA na CES 2026
intuitivo. A GIGABYTE reformulou a interface do GiMATE, permitindo que o AI Power Gear III realize a troca direta do MUX sem a necessidade de entrar na BIOS, enquanto o GiMATE Creator adiciona recursos de imagem Qwen e o GiMATE Coder amplia a funcionalidade de codificação intuitiva. As atualizações de hardware
More news about: GIGABYTE
Jan 06, 2026, 00:42 ET GIGABYTE presenta «Refine & Define», que perfila el futuro de la computación con IA en el CES 2026
intuitivo. GIGABYTE ha rediseñado la interfaz de GiMATE, permitiendo que AI Power Gear III realice el cambio directo de MUX sin necesidad de acceder a la BIOS. Además, GiMATE Creator incorpora las capacidades de Qwen-image, mientras que GiMATE Coder amplía las funciones de programación intuitiva. Las mejoras
More news about: GIGABYTE
Jan 06, 2026, 00:36 ET GIGABYTE presenta su filosofía "Refine & Define" en CES 2026 para definir el futuro de la computación con IA
para un control más intuitivo. GIGABYTE rediseñó la interfaz de GiMATE, que le permite al AI Power Gear III llevar a cabo el MUX switch sin entrar al BIOS, mientras que GiMATE Creator añade capacidades de Qwen-image, y GiMATE Coder amplía la funcionalidad de codificación intuitiva. Las actualizaciones en
More news about: GIGABYTE
Jan 05, 2026, 22:30 ET 技嘉發表會「Refine & Define」以精煉效能為核心，推動 AI 運算新時代
Studio 等生成式 AI 工作負載的運算效率。而在筆電部分，技嘉獨家搭載的智慧 AI 夥伴 GiMATE 現已全面升級，使用者可藉由 GiMATE 啟用 AI Power Gear III 進行 MUX 切換，無需進入 BIOS 設定。此外，GiMATE 的應用持續擴展，GiMATE Creator 現已支援 Qwen-image 影像生成，而 GiMATE Coder 則持續強化智慧程式開發功能，為創作者與開發者提供更多樣的選擇。此外，技嘉同步針對 AORUS MASTER 16、AERO X16 與 GAMING A18
More news about: GIGABYTE
Jan 05, 2026, 22:30 ET GIGABYTE Unveils "Refine & Define" Shaping Future of AI Computing at CES 2026
feature for intuitive control. GIGABYTE redesigned the GiMATE interface, allowing AI Power Gear III to perform direct MUX switching without entering the BIOS, while GiMATE Creator adds Qwen-image capabilities, and GiMATE Coder expands intuitive coding functionality. Hardware upgrades across the AORUS MASTER
More news about: GIGABYTE
Jan 05, 2026, 22:30 ET 기가바이트, CES 2026서 'Refine & Define' 공개…AI 컴퓨팅 미래 제시
극대화한다.노트북 부문에서는 기가바이트 전용 AI 에이전트 'GiMATE'를 선보인다. GiMATE는 고급 대규모 언어 모델(LLM)이 적용되어, '누르고 말하기(Press and Speak)' 기능을 통해 직관적인 제어가 가능하다. 새롭게 개선된 GiMATE UI를 통해 BIOS 진입 없이 AI Power Gear III로 MUX 스위칭을 수행할 수 있으며, GiMATE Creator에는 Qwen-image 기능을, GiMATE Coder에는 보다 직관적인 코딩 기능을 추가했다. AORUS MASTER 16, AERO X16, GAMING
More news about: GIGABYTE
Jan 05, 2026, 22:30 ET GIGABYTE Unveils "Refine & Define" Shaping Future of AI Computing at CES 2026
feature for intuitive control. GIGABYTE redesigned the GiMATE interface, allowing AI Power Gear III to perform direct MUX switching without entering the BIOS, while GiMATE Creator adds Qwen-image capabilities, and GiMATE Coder expands intuitive coding functionality. Hardware upgrades across the AORUS MASTER
More news about: GIGABYTE
Jan 05, 2026, 22:30 ET GIGABYTE präsentiert „Refine & Define" - die Zukunft des KI-Computings auf der CES 2026
Speak"-Funktion für intuitive Bedienung. GIGABYTE hat die GiMATE-Oberfläche neu gestaltet, sodass AI Power Gear III direkte MUX-Umschaltungen ohne Aufruf des BIOS durchführen kann, während GiMATE Creator um Qwen-Image-Funktionen erweitert wurde und GiMATE Coder intuitive Programmierfunktionen bereitstellt. Hardware-Upgrades
More news about: GIGABYTE